SSTR2 and neoplasm: It was discovered that [212Pb]Pb-DOTAMTATE has a superior T/K AUC ratio over other SSTR2-targeting peptides when radiolabeled with 212Pb, indicating favorable tumor retention and a more favorable dosimetry profile.